News

Eli Lilly sues telehealth companies selling compounded Zepbound, Mounjaro
Eli Lilly is suing four telemedicine companies selling compounded versions of its blockbuster obesity drug Zepbound and its ...
Zacks Investment Research on MSN3d
Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know
Eli Lilly (LLY) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...
Everything to know about the new weight loss pill that works as well as Ozempic — and when you can get it
Drug manufacturer Eli Lilly announced this week that an encouraging clinical trial of their new pill promises a convenient, ...
Seeking Alpha6d
Eli Lilly: Cementing Its GLP-1 Empire With Orforglipron's Promising Phase 3 Results
As for Eli Lilly’s 2025 outlook, it guided for full-year revenues between $58 billion and $61 billion, representing 32% growth at the midpoint. The company ... Next, I conduct a sensitivity ...